Evidence map›Paper›PMID 29806834›Full record

ArticleJournal of visualized experiments : JoVE2018

Long-term Live-cell Imaging to Assess Cell Fate in Response to Paclitaxel.

Amanda F Bolgioni, Marc A Vittoria, Neil J Ganem

Abstract readVideo-Audio Media
In one paragraph

Article in Journal of visualized experiments : JoVE, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. COMethods and protocols · 2024
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Amanda F BolgioniDepartment of Pharmacology & Experimental Therapeutics, Boston University School of Medicine.
Marc A VittoriaDepartment of Pharmacology & Experimental Therapeutics, Boston University School of Medicine.
Neil J GanemDepartment of Pharmacology & Experimental Therapeutics, Boston University School of Medicine; Department of Medicine, Section of Hematology and Oncology, Boston University School of Medicine; nganem@bu.edu.

Funding

TRAINING IN BIOMOLECULAR PHARMACOLOGYT32GM008541 · NIGMS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI FARB, DAVID H · 1997 to 2022
$5.2M
Regulation of cell growth and proliferation by the Hippo pathwayR01GM117150 · NIGMS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI NEIL J. GANEM · 2016 to 2026
$2.4M
Defining novel pathways that arrest genetically unstable tetraploid cellsR00CA154531 · NCI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI GANEM, NEIL J. · 2013 to 2015
$723k
Defining novel pathways that arrest genetically unstable tetraploid cellsK99CA154531 · NCI · DANA-FARBER CANCER INST · PI GANEM, NEIL J. · 2011 to 2012
$300k
NCI NIH HHS K99 CA154531NCI NIH HHS R00 CA154531NIGMS NIH HHS R01 GM117150NIGMS NIH HHS T32 GM008541
6 · The paper itself

Abstract

Live-cell imaging is a powerful technique that can be used to directly visualize biological phenomena in single cells over extended periods of time. Over the past decade, new and innovative technologies have greatly enhanced the practicality of live-cell imaging. Cells can now be kept in focus and continuously imaged over several days while maintained under 37 °C and 5% CO2 cell culture conditions. Moreover, multiple fields of view representing different experimental conditions can be acquired simultaneously, thus providing high-throughput experimental data. Live-cell imaging provides a significant advantage over fixed-cell imaging by allowing for the direct visualization and temporal quantitation of dynamic cellular events. Live-cell imaging can also identify variation in the behavior of single cells that would otherwise have been missed using population-based assays. Here, we describe live-cell imaging protocols to assess cell fate decisions following treatment with the anti-mitotic drug paclitaxel. We demonstrate methods to visualize whether mitotically arrested cells die directly from mitosis or slip back into interphase. We also describe how the fluorescent ubiquitination-based cell cycle indicator (FUCCI) system can be used to assess the fraction of interphase cells born from mitotic slippage that are capable of re-entering the cell cycle. Finally, we describe a live-cell imaging method to identify nuclear envelope rupture events.

Indexed as

Cell DifferentiationCell Line, TumorCulture TechniquesHumansPaclitaxelPaclitaxel

Identifiers

PMID29806834
PMCPMC6101178

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.